Chapple, Christopher R.
Christopher R Chapple investigador
Chapple, Christopher R. 1955-
Chapple, Christopher
Chapple, Christopher (Christopher R.)
VIAF ID: 44529089 (Personal)
Permalink: http://viaf.org/viaf/44529089
Preferred Forms
- 200 _ | ‡a Chapple ‡b Christopher R.
-
- 100 1 _ ‡a Chapple, Christopher
- 100 1 _ ‡a Chapple, Christopher R
-
-
- 100 1 _ ‡a Chapple, Christopher R.
-
-
-
-
- 100 1 _ ‡a Chapple, Christopher R.
-
- 100 1 _ ‡a Chapple, Christopher R.
- 100 1 _ ‡a Chapple, Christopher R. ‡d 1955-
- 100 1 _ ‡a Chapple, Christopher R. ‡d 1955-
-
- 100 0 _ ‡a Christopher R Chapple ‡c investigador
4xx's: Alternate Name Forms (11)
Works
Title | Sources |
---|---|
Badania urodynamiczne | |
Basic urological sciences | |
Benign prostatic hyperplasia | |
Le bilan urodynamique facile | |
BPH disease management : proceedings of a Satellite Symposium held at the XIV Congress of the European Association of Urology, Stockholm, April 7, 1999 | |
Budowa, funkcje oraz mechanizmy kontrolne dolnego odcinka układu moczowego | |
Dysfunkacja neurogenna pęcherza moczowego | |
Functional reconstruction of the urinary tract and gynaeco-urology : an exposition of functional principles and surgical procedures | |
Kliniczna ocena dolnych dróg moczowych | |
Male LUTS/BPH Made Easy | |
Managing bladder overactivity, 2002: | |
Multidisciplinary management of female pelvic floor disorders | |
Overactive bladder in clinical practice | |
Pęcherz moczowy marski | |
Pharmacologic responses of the mouse urinary bladder | |
A pilot study for a randomized controlled trial comparing the efficacy, safety and cost-effectiveness of surgical treatments of the prostate. | |
Pre- and post-junctional bradykinin B2 receptors regulate smooth muscle tension to the pig intravesical ureter. | |
A prospective audit of the use of a prostate clinic | |
A prospective patient-centred evaluation of urethroplasty for anterior urethral stricture using a validated patient-reported outcome measure | |
A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome | |
Prostatic obstruction : pathogenesis and treatment | |
Pyoderma gangrenosum of the penis: an interesting penile lesion | |
Randomised controlled trials versus real life practice in BPH. Introduction and concluding remarks. | |
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder | |
Recent developments in the management of detrusor overactivity | |
Reconstructive urology in the tropical and developing world | |
Relationship between overactive bladder (OAB) and irritable bowel syndrome (IBS): concurrent disorders with a common pathophysiology? | |
Renal adenocarcinoma in young adults | |
Renal angiomyolipoma: a comparison of 5 cases diagnosed by CT scan | |
Reply from Author re: Stephan Madersbacher. OnabotulinumtoxinA for Idiopathic Overactive Bladder Symptoms: Many Answers but More Questions. Eur Urol 2013;64:257–9 | |
The role of M2 muscarinic receptor subtypes mediating contraction of the circular and longitudinal smooth muscle of the pig proximal urethra | |
Surgery for stroke | |
Synthetic Vaginal Tapes for Stress Incontinence: Proposals for Improved Regulation of New Devices in Europe | |
Systematic review and evaluation of methods of assessing urinary incontinence. | |
Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women. | |
Systematic Review of Combination Drug Therapy for Non-neurogenic Lower Urinary Tract Symptoms | |
A systematic review of surgical techniques used in the treatment of female urethral stricture | |
Terminology report from the International Continence Society | |
Therapeutic use of electrical stimulation of peripheral nerves to modulate lower urinary tract function and symptoms. | |
Tissue-engineered buccal mucosa urethroplasty-clinical outcomes | |
Tissue engineering in urethral reconstruction--an update | |
Tissue engineering of the urethra: where are we in 2019? | |
Tolterodine: selectivity for the urinary bladder over the eye (as measured by visual accommodation) in healthy volunteers | |
Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers | |
Triumph | |
Triumph: improving the management of lower urinary tract symptoms in real life practice | |
The ultrasound cystodynamogram—a new radiological technique | |
The underactive bladder: detection and diagnosis | |
Urodynamics made easy | |
Urodynamika : to proste | |
Vaginal Surgery for Incontinence and Prolapse | |
The value of prostate specific antigen | |
What are the causes and consequences of bladder overdistension? ICI-RS 2011. | |
What Do We Really Know About Antimuscarinic Therapy for Adult Neurogenic Detrusor Overactivity? | |
What is New in Functional Urology? | |
What is the evidence for the management of urethral amyloidosis? A systematic review of the literature | |
What is the feasibility of switching to 200IU OnabotulinumtoxinA in patients with detrusor overactivity who have previously received 300IU? | |
What was hot at the ICS meeting 2014? | |
Whatʼs topical in functional reconstruction and trauma - with particular reference to urethroplasty | |
Which muscarinic receptor is important in the bladder? | |
Which Preparation of Botulinum Toxin A Should Be Used, Where Should It Be Injected, and How Should Its Efficacy Be Assessed? | |
Words of wisdom: Re: The challenges facing academic urology training programs: an impending crisis | |
Xanthogranulomatous pyelonephritis. A reappraisal and immunohistochemical study. | |
Zaburzenia czucia pęcherzowego | |
Zenritsusen hidaisho BPH : Windowsban. | |
The β3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome | |
β3-Agonist Therapy: A New Advance in the Management of Overactive Bladder? | |
সম্পাদকীয় | |
前立腺肥大症(BPH) |